CRBU
Caribou Biosciences Inc
1.20$
-0.8%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
Caribou Biosciences Inc (CRBU) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -111 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -32 | -33 | -33 | -91 | -93 | -138 | -111 | |
| 0.8 | 0.9 | 1.0 | 1.6 | 3.5 | 3.9 | 3.6 | |
| 1.2 | 1.0 | 3.4 | 12 | 14 | 17 | 13 | |
| -1.1 | 0.0 | 1.9 | 12 | – | – | – | |
| -8.3 | 0.2 | 29 | -4.2 | -7.3 | -5.1 | -0.5 | |
| 0.9 | 1.3 | 3.1 | 7.1 | 12 | 6.5 | 1.4 | |
| 27 | 6.4 | -176 | -93 | -68 | 87 | 102 | |
| – | – | 432 | – | – | – | – | |
| 0.0 | 1.5 | 1.0 | 0.0 | – | – | – | |
| 0.2 | 1.7 | 433 | 2.1 | 154 | 17 | 4.8 | |
| -4.6 | -25 | 225 | -182 | -7.2 | -35 | -3.9 | |
| -33 | -35 | -36 | -98 | -105 | -145 | -112 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.